US equities
|
MU
$1,088.00
▲+4.06%
NVDA
$237.36
▼-0.79%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.75
▼-0.77%
INTC
$113.06
▲+0.50%
MU
$1,088.00
▲+4.06%
NVDA
$237.36
▼-0.79%
SNDK
$1,692.42
▲+1.92%
SPCX
$167.60
▼-2.51%
AMD
$645.86
▼-0.55%
AAPL
$336.67
▲+0.91%
TSLA
$377.75
▼-0.77%
INTC
$113.06
▲+0.50%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:IKT
Recent news which mentions NASDAQ:IKT
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024
August 14, 2024
Tickers
IKT
Tags
Earnings Reports
Market News
IKT
From
InvestorPlace
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024
May 16, 2024
Tickers
IKT
Tags
IKT
Market News
Earnings Reports
From
InvestorPlace
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q4 2023
March 27, 2024
Tickers
IKT
Tags
Market News
IKT
NASDAQ:IKT
From
InvestorPlace
Inhibikase Therapeutics: A Novel And Promising Approach To Neurodegeneration And Oncology
May 24, 2023
Tags
NASDAQ:IKT
From
News Direct